Glucagon-like peptide-1 receptor agonists in non-alcoholic fatty liver disease: An update

Non-alcoholic fatty liver disease (NAFLD) is the predominant cause of chronic liver disease worldwide. NAFLD progresses in some cases to non-alcoholic steatohepatitis (NASH), which is characterized, in addition to liver fat deposition, by hepatocyte ballooning, inflammation and liver fibrosis, and i...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:World J Hepatol
Egile Nagusiak: Sofogianni, Areti, Filippidis, Athanasios, Chrysavgis, Lampros, Tziomalos, Konstantinos, Cholongitas, Evangelos
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Baishideng Publishing Group Inc 2020
Gaiak:
Minireviews
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7475780/
https://ncbi.nlm.nih.gov/pubmed/32952876
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4254/wjh.v12.i8.493
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak